Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
Ferraro F, Gruszczynska A, Ruzinova MB, Miller CA, Percival ME, Uy GL, Pusic I, Jacoby MA, Christopher MJ, Kim MY, Westervelt P, Cashen AF, Schroeder MA, DiPersio JF, Abboud CN, Wartman LD, Gao F, Link DC, Ley TJ, Welch JS.
Ferraro F, et al. Among authors: schroeder ma.
Haematologica. 2022 Jul 1;107(7):1709-1713. doi: 10.3324/haematol.2021.280153.
Haematologica. 2022.
PMID: 35236053
Free PMC article.
No abstract available.